About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Memorial Sloan Kettering Cancer Center
https://www.mskcc.org/healthcare-professionals
Refer a Patient to MSKCC:
mskcc.org/refer
COVID-19
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
Events
MPN
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
SOHO 2021 Update on NY-ESO-1 TCR T-Cell Therapy
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Adam Schoenfeld
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Adam Schoenfeld
37 views
October 1, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Hematologic Transplantation and Malignancies
11:20
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Validation of the Composite CR Definitions …
Feat.
J. Bewersdorf
11:00
ASH 2022 Conference Coverage
ASH 2022: Management of Accelerated and Blast-Phase MPN
Feat.
R. Rampal
23:13
MDS Foundation
MDS Foundation ASH 2021 Review: Towards a Genetically Inspired Class…
Feat.
E. Bernard
11:04
ASH 2021 Conference Coverage on VuMedi
ASH 2021: Evaluation of IWG 2006 Response Criteria in Patients with …
Feat.
J. Bewersdorf
17:46
2021 International Congress on Myeloproliferative Neoplasms
Which Published Schemas Are Helpful in MPN Transplant Decisions?
Feat.
S. Giralt
14:46
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on NY-ESO-1 TCR T-Cell Therapy
Feat.
A. Schoenfeld
10:40
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: A Tumor-Agnostic TCR-Mimic CAR T-Cell Specific for NDC80 …
Feat.
M. Klatt
11:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Highlights on CARs for Solid Tumors
Feat.
R. O'Cearbhaill
24:52
SOHO Highlights: State of the Art and Next Questions
CAR-T State of the Art: What Therapies Will Be Available in the Next…
Feat.
S. Giralt
18:48
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on CARs: How Does the Ideal Next-Gen CAR T-Cell…
Feat.
R. Brentjens
16:23
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on Myelofibrosis: What Is the Distinctive Featu…
Feat.
R. Rampal
16:42
University of Miami's 2nd Biennial Miami Leukemia Symposium
IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of R…
Feat.
E. Stein
40:55
Memorial Sloan Kettering Cancer Center
Hematopoietic Stem Cell Transplant: Difference Between AutoHSCT and …
Feat.
M. Perales
23:23
Memorial Sloan Kettering Cancer Center
Complication of AlloHSCT: Phases of Complications, Classification of…
Feat.
M. Perales
17:30
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
CNS Toxicity of CAR-T in Hematologic Malignancies: Clinical Manifest…
Feat.
B. Santomasso
65:45
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Setting Up a CAR T Program Ins and Outs: Institutional Program Devel…
Feat.
S. Giralt
23:38
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokin…
Feat.
B. Santomasso